Cornelius Sailer

Cornelius Sailer is an experienced executive in the pharmaceutical sector, currently serving as the Executive Director of Global Product Strategy for Inflammation & Autoimmunity at Incyte since April 2021. Previously, Cornelius had a significant tenure at Sanofi from July 2007 to April 2021, where roles included leadership in Global Life Cycle Management for dupilumab and the Renal & Biosurgery divisions. Cornelius also held various director positions at Novartis Pharmaceuticals Corporation, focusing on women's health and life cycle management. Early career experiences include roles in sales and marketing at Rhone-Poulenc Rorer and Stiefel, a GSK company. Cornelius holds a Master's degree in Health Law/Policy and Intellectual Property from Seton Hall University School of Law and a Bachelor's degree in Biology/Chemistry from the University of Northern Colorado.